Anthony Taparo - Mar 15, 2022 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Growth Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Stock symbol
SGRY
Transactions as of
Mar 15, 2022
Transactions value $
-$452,496
Form type
4
Date filed
3/17/2022, 05:43 PM
Previous filing
Mar 15, 2022
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale -$366K -7.43K -6.55% $49.30 106K Mar 15, 2022 Direct F1, F2
transaction SGRY Common Stock Sale -$86.4K -1.7K -1.6% $50.88 104K Mar 16, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.